Nektar Therapeutics (NKTR) Covered Calls

Nektar Therapeutics covered calls Nektar Therapeutics, Inc. is clinical-stage biopharmaceutical Company, which is engaged in the development of drug candidates that utilize its PEGylation & advanced polymer conjugate technology platforms.

You can sell covered calls on Nektar Therapeutics to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NKTR (prices last updated Wed 3:20 PM ET):

Nektar Therapeutics (NKTR) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
35.29 +0.12 35.29 35.31 604K 10 6.1B
Covered Calls For Nektar Therapeutics (NKTR)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jun 21 35.5 0.30 35.01 0.9% 110%
Jul 19 35 2.10 33.21 5.4% 63.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Its products includes of drug candidates of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. The company provides small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient. The company was founded in 1990 and is headquartered in San Francisco, CA.